Aspire-Lakewood (ASBP) vs Medicus Pharma (MDCX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aspire-Lakewood (ASBP) has outperformed Medicus Pharma (MDCX) over the past year, losing 39.9% versus a loss of 93.4%. Aspire-Lakewood is the larger company by market cap ($12.0 million vs $7.4 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASBP | MDCX |
|---|---|---|
| Share price | $8.56 | $0.1029 |
| Market cap | $12.00M | $7.38M |
| 1-day change | -0.87% | -35.77% |
| YTD return | +63.45% | -89.53% |
| 1-year return | -39.90% | -93.38% |
| EPS (TTM) | $-31.16 | $-2.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.76 | $2.78 |
| 52-week low | $0.11 | $0.1026 |
| Distance from 52-week high | -54.40% | -96.30% |
| Average volume | 36.92K | 4.43M |
| Shares outstanding | 1.40M | 71.71M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ASBP has outperformed MDCX by 53.5 percentage points over the past year.
ASBP vs MDCX FAQ
Which is bigger, Aspire-Lakewood or Medicus Pharma?
Aspire-Lakewood (ASBP) is larger, with a market capitalization of $12.00M compared with $7.38M for Medicus Pharma (MDCX).
Which stock has performed better over the past year, ASBP or MDCX?
ASBP returned -39.90% over the past 12 months, compared with -93.38% for MDCX (price return, excluding dividends). Past performance does not predict future results.
Are Aspire-Lakewood and Medicus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.